ULTRASE MT 20 (Ultrase MT 20 65,000 units amylase; 20,000 units lipase; 65,000 units protease)
Generic Name: pancrelipase
Pill imprint ULTRASE MT 20 has been identified as Ultrase MT 20 65,000 units amylase; 20,000 units lipase; 65,000 units protease.
Ultrase MT 20 is used in the treatment of pancreatic exocrine dysfunction; chronic pancreatitis; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Ultrase MT 20 65,000 units amylase; 20,000 units lipase; 65,000 units protease is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- ULTRASE MT 20
- 65,000 units amylase; 20,000 units lipase; 65,000 units protease
- Gray / Yellow
- Rx and/or OTC
- Drug Class:
- Digestive enzymes
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Axcan Scandipharm Inc.
- National Drug Code (NDC):
More about Ultrase MT 20 (pancrelipase)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.